Get started Log in

PHARM — Pharming Share News

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapNeutral

Market Cap
€771.69m
Enterprise Value
€704.43m
Revenue
$376.13m

Pharming Group jumps after positive trial results for immune disease drug
11/12/2024 08:58
Brief: Pharming Announces Positive Topline Results For Pediatric Clinical Trial Of Leniolisib
11/12/2024 06:17
Brief: Pharming Group On Track To Meet 2024 Total Revenue Guidance
24/10/2024 06:42
Brief: Pharming Group 9M EPS USD -0.022
24/10/2024 06:00
Brief: Pharming Group Starts Phase II Trial For Leniolisib In PIDs
10/10/2024 06:02
Pharming Group rises on UK marketing authorization for drug Joenja
26/09/2024 08:25
Brief: Pharming Group Announces Marketing Authorization In U.K. For Joenja® (Leniolisib)
26/09/2024 06:09
Pharming Group NV reports results for the quarter ended in January - Earnings Summary
01/08/2024 07:02
Brief: Pharming Group Is On Track For 2024 Total Revenue Guidance
01/08/2024 06:39
Brief: Pharming Group H1 EPS USD -0.02
01/08/2024 06:00
Brief: Pharming Group Says Provides Update On Ongoing Regulatory Review Of Leniolisib For Treatment Of APDS In EU
30/05/2024 21:47
Early Redemption Of Remaining Outstanding Convertible Bonds
15/05/2024 06:16
Brief: Pharming Group Q1 Revenues Up At $55.6 Million
08/05/2024 06:33
Brief: Pharming Group Q1 Revenue USD 46 Million
08/05/2024 06:00
Brief: Pharming Group Issues EUR 100 Million Convertible Bonds Due 2029
18/04/2024 14:18
Brief: Pharming Group Launches About EUR 100 Mln Bonds Offering
18/04/2024 07:05
Brief: Pharming Group Completes Enrollment In Pediatric Clinical Trial Of Leniolisib
08/04/2024 06:06
Pharming Group slips on 2023 net loss, 'weak' guidance
14/03/2024 10:10
Brief: Pharming Group FY EPS USD -0.015
14/03/2024 06:10
Brief: Pharming Group Expects 2024 Total Revenue Of $280 Mln - $295 Mln
14/03/2024 06:07